Share |

UC Irvine Diabetes Center

 333 City Blvd. West, Suite 605
 Orange, CA 92868
[P] (714) 5092101
[F] (714) 4563703
www.ucidiabetes.com
www.ucifoundation.org
[email protected]
Sasha Advani
FOUNDED: 1965
INCORPORATED: 1967
 Printable 1 Page Summary
 Printable Profile
Organization DBA UC Irvine Diabetes Center
Former Names --
Organization received a competitive grant from the community foundation in the past five years No
Employer Identification Number 95-2540117 --

Summary


Mission StatementMORE »

The mission of the UC Irvine Diabetes center is to be a center of integrity and responsibility dedicated to preventing diabetes, improving care and advancing science to find a cure. Our vision is to save lives and reduce human suffering today, and prevent diabetes and find a cure tomorrow.

Mission Statement

The mission of the UC Irvine Diabetes center is to be a center of integrity and responsibility dedicated to preventing diabetes, improving care and advancing science to find a cure. Our vision is to save lives and reduce human suffering today, and prevent diabetes and find a cure tomorrow.

FinancialsMORE »

Fiscal Year 2019
Projected Expenses $1,000,000.00
Projected Revenue $900,000.00

ProgramsMORE »

  • Diabetes Type 1 Research
  • Type 2 Diabetes Research

Revenue vs. Expense ($000s)

Expense Breakdown 2017 (%)

Expense Breakdown 2016 (%)

Expense Breakdown 2015 (%)

For more details regarding the organization's financial information, select the financial tab and review available comments.


Overview


Mission Statement

The mission of the UC Irvine Diabetes center is to be a center of integrity and responsibility dedicated to preventing diabetes, improving care and advancing science to find a cure. Our vision is to save lives and reduce human suffering today, and prevent diabetes and find a cure tomorrow.

Background Statement

UC Irvine Diabetes Center was founded in 2005 and has become the leading treatment and research center for types 1 and 2 diabetes in the western United States. Patients from around Orange County, across the country and the world come to UC Irvine Diabetes Center for treatment. Here at UC Irvine, leaders in the field of diabetes research are pursuing discoveries that will improve the quality of life for diabetes patients, and work toward a cure. Our research findings will assist scientists all over the world in the challenge to prevent, control and find a cure for diabetes. Because UC Irvine is a leading diabetes research center, it attracts top PhD research candidates from all over the world. These graduate students are a vital part of the team, advancing research to treat and cure diabetes.

ONE WORLD. Today, more than 220 million people in the world live with diabetes. By the 2030, that figure is estimated to grow to 360 million, according to the World Health Organization. Diabetes knows no boundaries, socioeconomic level, skin color or gender. What we do know is that diabetes continues to cause life-threatening complications, and that one in three children will be diagnosed with diabetes in their adult lives. These statistics drive the UC Irvine Diabetes Center to action.   

ONE GOAL. As a clinical facility with staff endocrinologists, nutritionists and certified diabetes educators, the center treats the whole patient, not just the disease. As part of UC Irvine, a top-tier research institution, the center is at the forefront of research, with a multi-faceted, multi-disciplinary team of scientists from around the world who are actively pursuing better treatments to help diabetes patients live well today.

A CURE. From understanding the cardiovascular complications of diabetes to an exciting development in the area of immune therapy, UC Irvine Diabetes Center has a team of world-renowned scientists and researchers working to find a cure. For some, a cure means an end to insulin shots and blood tests. For others, it means an end to complications. For all, we envision a world without diabetes.  

Impact Statement

As part of Orange County's only university medical center, the diabetes center, led by medical director Ping H. Wang, MD has a multidisciplinary team of specialists able to treat the full spectrum of complications that diabetic patients can experience, from vision, vascular and neurological complications to heart and kidney disease.

UC Irvine Diabetes Center scientists are taking bold approaches to understand the molecular mechanisms underlying the development of diabetes and exploring new ways to treat diabetes patients and improve their quality of life.  These projects take team approaches that combine molecular medicine, basic biology, engineering, informatics (computer power) analysis, and health policy decisions. This unique format sets the team apart from researchers nationwide. Our research findings will assist scientists all over the world in the challenge to prevent, control and find a cure for diabetes. 

UC Irvine’s leading stem cell research has also allowed Dr. Wang's team at UC Irvine Diabetes Center to develop a unique method to produce stem cells from adult patient skin cells. The research team is working closely with leading experts at the UC Irvine Sue & Bill Gross Stem Cell Research Center to develop new methods to convert a patient’s own skin cells into heart muscle cells and pancreas insulin-producing islet cells for eventual cell replacement therapy for diabetic patients.

Type 1 Diabetes

Damage to islet cells in the pancreas lead to Type 1 diabetes. Our scientists have developed a potential drug that prevents the immune system from destroying islet cells. This drug has been licensed by a pharmaceutical company and is currently undergoing clinical trials.

In the next five years, we will investigate the mechanisms through which our body controls islet cells in the pancreas, identify the defects of islet cell function in diabetes, and seek new opportunities to correct these defects and restore insulin secretion.

Type 2 Diabetes

Insulin resistance and obesity are major causes of Type 2 Diabetes. Our team has identified new defects that led to insulin resistance and obesity in experimental animals and humans and caused diabetes and obesity.

In the next five years, we will develop new ways to correct these defects, improve insulin resistance, reduce obesity and improve glucose control. We have created an animal model of diabetes heart disease based on the defects we have discovered. Our team will develop new strategies to protect the heart from diabetes damage.


Needs Statement

Diabetes is one of the world’s most rapidly growing epidemics and UC Irvine Diabetes Center is leading the effort to find a cure. Approximately $18 million in grants has been awarded to Diabetes Center scientists from leading agencies such as the National Institutes of Health (NIH), a marker of the significance of their efforts. With the diminishing levels of NIH funding, however, the private sector has become increasingly critical to ensuring that early to mid-career researchers – those researchers whose new ideas and approaches most need encouraging – have the support they need to explore and advance the most promising areas of research. This entails securing two to three years of financial support for each young researcher. Our community’s participation is vital to funding the full range of research in a thriving Center, from seed funds for exciting new ideas, resources to recruit the most promising post-doctoral fellows, and investments in technology and equipment that define a state of the art lab. Financial contributions from individuals, companies and foundations are vital to the Center’s ability to significantly advance the search for a cure, save lives through leading edge care, and improve the health of diabetes patients today.

I. RESEARCH LAB EQUIPMENT NEEDS $150,000

Top-tier research requires state-of-the-art laboratory equipment. In recent years, new technologies have opened the door to profound new research capabilities. Powerful new instruments allow researchers to see the smallest particles and screen them at a much faster rate. What used to take weeks or months can now be done in a matter of days. With the support of generous donors, the Diabetes Center recently acquired AB Sciex MALDI 5800, GE Typhoon FLA 9500, and TSE LabMaster. Diabetes Center scientists and students use these instruments to systematically study the fundamental mechanisms of diabetes and its complications. The results of research revealed promising biological targets that can lead researchers to drug candidates that improve the quality of life for diabetics.

II. RESEARCH FELLOW SUPPORT $250,000

Because UC Irvine is a leading research center, we are able to attract top PhD candidates from all over the world, and therefore accept only students with very the highest academic performance.

Each year, two new fellows are selected from a highly competitive pool of applicants to support diabetes research in the unique environment within the Sue & Bill Gross Stem Cell Research Center at UC Irvine. A total of ten fellows support some of the country’s leading diabetes researchers for up to five years, working to identify innovative new treatment therapies as well as identifying a cure for the disease. Contributed funds are vital to providing students with much-needed support for study-related expenses, such as housing, computers, books, supplies and conferences.

III. DRUG DISCOVERY RESEARCH FUND $250,000

At UC Irvine Diabetes Center, private philanthropy has been instrumental in providing physicians and scientists with the resources to explore new and ever-changing medical science. Through this fund, donors may direct their gifts to advances in research directed toward discovering novel new drug therapies to improve the treatment of diabetes - discoveries not supported by private sector drug companies. The advanced technology at UC Irvine Diabetes Center facilitates ongoing research on promising biological targets that could one day identify drug candidates to improve the quality of life for diabetics - drugs that reduce complications, treat obesity, improve glucose control, and possibly, even cure the disease.

IV. WISH FOR A CURE FUND $200,000

Through the Wish for a Cure Fund, donors may direct their gifts to advances in research for treatment of and ultimately a cure for Type I diabetes. Wish for a Cure gifts will be used to develop innovative pilot studies and further research projects to greatly enhance the speed and quality of our most promising discoveries for Type I diabetes. Supporters of the Wish for a Cure Fund become partners in this important initiative, and are provided with personal updates by the Diabetes Center’s Director, Dr. Ping Wang, and his research team.

V. NAMING OPPORTUNITIES

Gifts to dedicate spaces or build endowment support within the Diabetes Center offer specialized recognition to donors who wish to create a legacy at UC Irvine, while generously supporting the capital or research needs of the Center. Opportunities include:

UC Irvine Diabetes Center 
UC Irvine Diabetes Center Clinic 
Endowed Diabetes Research Laboratory 
Endowed Student Research Fellowship

CEO Statement

I am very proud that the UCI Diabetes Center has become the fastest growing diabetes center on the West Coast since we established our center eleven years ago. We are dedicated to preventing diabetes, providing cutting-edge care and advancing science to find a cure. Recently, our researchers have made exciting discoveries that may be used toward better prevention and treatment of diabetes in the future, including novel compounds for potential prevention of type 1 diabetes.

In addition, our endocrinology fellowship training program has become one of the most sought after endocrinology training programs in the western United States. This year alone over one hundred and fifty physicians applied and competed for two training spots.

Our clinic was recently recognized as the top diabetes center with the best patient outcomes in a survey among 16 diabetes centers across the United States, including the best average patient hemoglobin A1C! We are also making strides in our education and community outreach programs.

Ping H Wang, MD
Director, UCI Diabetes CenterProfessor of Medicine, Physiology and Biophysics, and Experimental Pathology
Chief, Division of Endocrinology, UCI Medical Center
Co-Director, UCI Stem Cell Training Program

Board Chair Statement

--

Other Ways to Donate/Volunteer

For more information about the center’s research, scheduling a lab tour, making a contribution or volunteering with us, call Sasha Advani at (714) 509-2101 or email [email protected] To make an online donation: http://www.connect.uci.edu/DiabetesCenter To make a donation by mail, please make checks payable to UCI Foundation, noting Diabetes Center in the memo line and send to: UC Irvine Diabetes Center, 333 City Blvd West, Suite #605, Orange, CA 92868.To make a gift by phone, please call our advancement office and talk with Sasha Advani at (714) 509-2101. For in-kind donations, please contact Sasha Advani at (714) 509-2101 or [email protected] To learn more about volunteer activities, please call Sasha Advani at (714) 509-2101.

Geographic Area Served

Central Orange County
West Orange County
South Orange County
North Orange County
The University of California, Irvine Center for Diabetes Treatment and Research is the West Coast’s authority on diabetes treatment and research. As part of UC Irvine, a top-tier research institution, the center is at the forefront of patient care, education and research.

Organization Categories

  1. Medical Research - Specifically Named Diseases Research
  2. Education - Higher Education
  3. Medical Research -

--

Programs


Diabetes Type 1 Research

UC Irvine Diabetes Center scientists are taking bold approaches to understand the molecular mechanisms underlying the development of diabetes and exploring new ways to treat diabetes patients and improve their quality of life. These projects take team approaches that combine molecular medicine, basic biology, engineering, informatics (computer power) analysis, and health policy decisions. This unique format sets the team apart from researchers nationwide. Our research findings will assist scientists all over the world in the challenge to prevent, control and find a cure for diabetes.

UC Irvine’s leading stem cell research has also allowed Dr. Wang's team at UC Irvine Diabetes Center to develop a unique method to produce stem cells from adult patient skin cells. The research team is working closely with leading experts at the UC Irvine Sue & Bill Gross Stem Cell Research Center to develop new methods to convert a patient’s own skin cells into heart muscle cells and pancreas insulin-producing islet cells for eventual cell replacement therapy for diabetic patients.

Budget  $500,000.00
Category  Medical Research, General/Other Diabetes Research
Population Served General/Unspecified
Program Short-Term Success 

Our scientists had developed a potential drug that prevented immune system from destroying islet cells. This drug has been licensed by pharmaceutical company and is currently undergoing clinical trial.

Program Long-Term Success 

Our ultimate goal is to find a cure for type 1 diabetes. In the next five years, we will investigate the mechanisms through which our body controls islet cells in pancreas, identify the defects of islet cell function in diabetes, and seek new opportunities to correct these defects and restore insulin secretion.

Program Success Monitored By  Our program success is measured by our team of the world's most outstanding diabetes specialists in both research and treatment. It is also measured by our our patients, seen at the Diabetes Center Clinic, who are offered world class care, which is informed by the latest research and delivered using best practices in the field.
Examples of Program Success 
We have made tremendous success in our research over the last few years. Our scientists had developed a potential drug that prevented immune system from destroying islet cells. This drug has been licensed by pharmaceutical company and is currently undergoing clinical trial.
In addition, with the help of research grants from NIH, the Diabetes Center has a multi-faceted approach to research that is unique in the nation.

Type 2 Diabetes Research

UC Irvine Diabetes Center scientists are taking bold approaches to understand the molecular mechanisms underlying the development of diabetes and exploring new ways to treat diabetes patients and improve their quality of life. These projects take team approaches that combine molecular medicine, basic biology, engineering, informatics (computer power) analysis, and health policy decisions. This unique format sets the team apart from researchers nationwide. Our research findings will assist scientists all over the world in the challenge to prevent, control and find a cure for diabetes.

UC Irvine’s leading stem cell research has also allowed Dr. Wang's team at UC Irvine Diabetes Center to develop a unique method to produce stem cells from adult patient skin cells. The research team is working closely with leading experts at the UC Irvine Sue & Bill Gross Stem Cell Research Center to develop new methods to convert a patient’s own skin cells into heart muscle cells and pancreas insulin-producing islet cells for eventual cell replacement therapy for diabetic patients.

Budget  $500,000.00
Category  Medical Research, General/Other Diabetes Research
Population Served General/Unspecified
Program Short-Term Success 

Insulin resistance and obesity are major causes of Type 2 Diabetes. Our team has identified new defects that led to insulin resistance and obesity in experimental animals and human and caused diabetes and obesity.

Program Long-Term Success  Our ultimate goal is to find a cure for type 2 diabetes.  In the next five years, we will develop new ways to correct defects, improve insulin resistance, reduce obesity and improve glucose control. We have created an animal model of diabetes heart disease based on the defects we have discovered. Our team will develop new strategies to protect the heart from diabetes damage.
Program Success Monitored By 

Our program success is measured by our team of the world's most outstanding diabetes specialists in both research and treatment. It is also measured by our our patients, seen at the Diabetes Center Clinic, who are offered world class care, which is informed by the latest research and delivered using best practices in the field.

Examples of Program Success 

We have made tremendous success in our research over the last few years. Our team has identified new defects that led to insulin resistance and obesity in experimental animals and human and caused diabetes and obesity. In addition, with the help of research grants from NIH, the Diabetes Center has a multi-faceted approach to research that is unique in the nation.


Management


CEO/Executive Director Ping H. Wang MD
CEO Term Start --
CEO Email [email protected]
CEO Experience

Dr. Ping Wang, UC Irvine Diabetes Center Director, is a Harvard-trained endocrinologist and an internationally recognized authority on diabetes. He received his diabetes training at the Joslin Diabetes Center in Boston. Dr. Wang is an active researcher in the area of diabetes complications and heart diseases and his laboratory is trying to define the molecular mechanisms of diabetic heart complications. As Center Director, Dr. Wang is responsible for the overall development of its diabetes research, education and patient care programs. In addition to his administrative, clinical, and research duties, Dr. Wang also participates in national clinical and research programs. For example, he has served as grant reviewer for the National Institutes of Health, UK Wellcome Trust, American Heart Association, etc. He has participated on the review panel for the American College of Physicians’ diabetes standards of care. He and his colleagues have published numerous research papers and commentary articles in leading journals. Dr. Wang is an Associate Professor of Medicine, Biological Chemistry, and Physiology at UC Irvine and also serves as Chief of Endocrinology, Diabetes and Metabolism at UC Irvine Medical Center.

Former CEOs and Terms

Name Start End
-- -- --

Senior Staff

Name Title Experience/Biography
Rhonda Halverson Executive Director of Development --

Awards

Award Awarding Organization Year
-- -- --

Affiliations

Affiliation Year
-- --

External Assessments and Accreditations

External Assessment or Accreditation Year
-- --

Collaborations

--

Staff Information

Number of Full Time Staff 0
Number of Part Time Staff 0
Number of Volunteers 35
Number of Contract Staff 2
Staff Retention Rate % --
Staff Professional Development --

Staff Demographics

Ethnicity African American/Black: --
Asian American/Pacific Islander: --
Caucasian: --
Hispanic/Latino: --
Native American/American Indian: --
Other: --
Other (if specified): --
Gender Female: --
Male: --
Not Specified --

Plans & Policies

Organization has Fundraising Plan? Yes
Organization has Strategic Plan? Under Development
Years Strategic Plan Considers 10
Management Succession Plan --
Organization Policies And Procedures --
Business Continuity of Operations Plan --

Risk Management Provisions

Nondiscrimination Policy --
Whistle Blower Policy Yes
Document Destruction Policy Yes
Directors and Officers Insurance Policy --

Reporting and Evaluations

Management Reports to Board? --
CEO Formal Evaluation and Frequency -- --
Senior Management Formal Evaluation and Frequency -- --
Non Management Formal Evaluation and Frequency -- --

Government Licenses

--

CEO Comments

--

Foundation Comments

--

Governance


Board Chair Dean Yoost
Board Chair Company Affiliation --
Board Chair Term -
Board Co-Chair --
Board Co-Chair Company Affiliation --
Board Co-Chair Term -

Board Members

Name Company Affiliations Status
Ash Ateshkadi PhD -- --
Susan Bowman PhD -- --
David Brownstein -- --
Anson Cain -- --
William Chatham -- --
David Chavez -- --
Rajer Choobak -- --
Brad Cohen -- --
Brian Gordon -- --
Greg Ko -- --
Chase Lewis -- --
Doug McCombs -- --
Brian Novak PhD -- --
Adrienne Thomas -- --
Jerry von Talge PhD -- --
Ping Wang MD Diabetes Center Director --
Dean Yoost -- --

Constituent Board Members

Name Company Affiliations Status
-- -- --

Youth Board Members

Name Company Affiliations Status
-- -- --

Additional Board Members and Affiliations

Name Company Affiliations Status
Brian Backstrom -- --
Robert Follman -- --
Roger Grad -- --
Rick Keller -- --
Eric Kramer -- --
Marybelle and Paul Musco -- --
Sue Parks -- --
Dan Pennington -- --
Robert Pfeif -- --

Board Demographics

Ethnicity African American/Black: 0
Asian American/Pacific Islander: 0
Caucasian: 0
Hispanic/Latino: 0
Native American/American Indian: 0
Other: --
Other (if specified): --
Gender Female: 0
Male: 0
Not Specified 0

Board Information

Board Term Lengths --
Board Term Limits --
Board Meeting Attendance % --
Written Board Selection Criteria Yes
Written Conflict Of Interest Policy Yes
Percentage of Monetary Contributions 100%
Percentage of In-Kind Contributions --
Board Orientation --

CEO Comments

--

Foundation Comments

--

Standing Committees

  • Board Development / Board Orientation
  • Marketing
  • Special Events (Golf Tournament, Walk / Run, Silent Auction, Dinner / Gala)

Financials


Revenue vs. Expense ($000s)

Expense Breakdown 2017 (%)

Expense Breakdown 2016 (%)

Expense Breakdown 2015 (%)

Prior Three Years Total Revenue and Expense Totals

Fiscal Year 2017 2016 2015
Total Revenue $705,620 $602,010 $698,870
Total Expenses $1,039,540 $1,034,242 $1,038,002

Prior Three Years Revenue Sources

Revenue By Revenue Source
Fiscal Year 2017 2016 2015
Foundation and
Corporation Contributions
$236,714 $151,911 $203,680
Government Contributions $0 $0 $0
    Federal -- -- --
    State -- -- --
    Local -- -- --
    Unspecified -- -- --
Individual Contributions $266,795 $403,774 $371,741
Indirect Public Support -- -- --
Earned Revenue -- -- --
Investment Income, Net of Losses -- -- --
Membership Dues -- -- --
Special Events $202,111 $46,325 $123,449
Revenue In-Kind -- -- --
Other -- -- --

Prior Three Years Expense Allocations

Expense By Type
Fiscal Year 2017 2016 2015
Program Expense $1,000,000 $1,000,000 $1,000,000
Administration Expense -- -- --
Fundraising Expense $39,540 $34,242 $38,002
Payments to Affiliates -- -- --
Total Revenue/Total Expenses 0.68 0.58 0.67
Program Expense/Total Expenses 96% 97% 96%
Fundraising Expense/Contributed Revenue 6% 6% 5%

Prior Three Years Assets and Liabilities

Assets and Liabilities
Fiscal Year 2017 2016 2015
Total Assets -- -- --
Current Assets -- -- --
Long-Term Liabilities -- -- --
Current Liabilities -- -- --
Total Net Assets -- -- --

Short Term Solvency

Fiscal Year 2017 2016 2015
Current Ratio: Current Assets/Current Liabilities nan nan nan

Long Term Solvency

Fiscal Year 2017 2016 2015
Long-term Liabilities/Total Assets nan% nan% nan%
Endowment Value --
Spending Policy Income Only
Percentage(If selected) --
Are you currently in a Capital Campaign? No
Capital Campaign Purpose --
Campaign Goal --
Capital Campaign Dates -
Capital Campaign Raised-to-Date Amount --
Capital Campaign Anticipated in Next 5 Years? --

CEO Comments

--

Foundation Comments

Summary financial data is per the Form 990s and consultation with the organization. Foundation/corporate and individual contributions are combined under Foundation and Corporation Contributions.

Documents


Other Documents

No Other Documents currently available.